Pablo Guzman - Jan 26, 2023 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Chief Medical Officer
Signature
/s/ Pablo Guzman
Stock symbol
ZVSA
Transactions as of
Jan 26, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2023, 07:25 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Stock Options (right to buy) Award $0 +100K $0.00 100K Jan 26, 2023 Common Stock 100K $2.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 3 equal annual installments commencing on January 26, 2024.